ANDROGEN RECEPTOR SUPPRESSORS IN THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER, ALOPECIA AND OTHER HYPER-ANDROGENIC SYNDROMES

• 1. 前列腺癌、脱发和其他雄激素过多综合征的治疗和诊断中的雄激素受体抑制剂 [P] . 中国专利： CN100402492C . 2008.07.16
• 2. 前列腺癌、脱发和其他雄激素过多综合征的治疗和诊断中的雄激素受体抑制剂 [P] . 中国专利： CN1416416A . 2003-05-07
• 3. ANDROGEN RECEPTOR SUPPRESSORS IN THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER, ALOPECIA AND OTHER HYPER-ANDROGENIC SYNDROMES [P] . 韩国专利： KR100508681B1 . 2005-08-17

  机译： 前列腺癌，恶性肿瘤和其他高雄激素性综合征的治疗和诊断中的雄激素受体抑制剂

• 4. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes [P] . AU2001236856B2 . 2005-08-11

  机译： 雄激素受体抑制剂在前列腺癌，脱发和其他高雄激素综合征的治疗和诊断中

• 5. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer alopecia and other hyper-androgenic syndromes. [P] . ZA200206497B . 2003-08-14

  机译： 雄激素受体抑制剂在前列腺癌脱发和其他高雄激素综合征的治疗和诊断中。

• 1. Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation [J] . John Lai, Jyotsna Batra 亚洲男性学杂志（英文版） . 2014,第005期
• 2. Speckle-typePOZ protein mutations interrupt tumor suppressor function of speckle-typePOZ protein in prostate cancer by affecting androgen receptor degradation [J] . John Lai, Jyotsna Batra 亚洲男性学杂志（英文版） . 2014,第009期
• 3. Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression [J] . You-Yi Lu, Bo Jiang, Fu-Jun Zhao, 亚洲男性学杂志（英文版） . 2013,第005期
• 4. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk [J] . British Journal of Cancer . 1999,第4期
• 5. Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19? [J] . Journal of cosmetic dermatology . 2020,第7期
• 6. Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy [J] . Zhang Keke, Yan Fei, Lei Xiaoying, Molecular medicine reports . 2018,第6aPta2期
• 7. Role of the Androgen Receptor and PI3K/Akt in the Survival of Androgen-Refractory Prostate Cancer Cells [C] . Haojie Huang, Donald J. Tindal International Symposium on Hormonal Carcinogenesis . 2005
• 8. Co-chaperone influence on androgen receptor signaling and identification of androgen receptor genes in prostate cancer. [D] . Prescott, Jennifer. 2007
• 9. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy but not to prostate cancer risk [O] . O Bratt, Å Borg, U Kristoffersson, 1999
• 10. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk [O] . Bratt, O, Borg, Å, Kristoffersson, U, 1999

• 1. Androgen Receptor Is a Tumor Suppressor and Proliferator in Prostate Cancer [J] . Yuanjie NIU ,Chawnshang CHANG . 中国肺癌杂志 . 2009,第006期
• 2. miR-141-3p Suppresses Expression of Androgen Receptors and Functions as a Tumor Suppressor Gene in Prostate Carcinogenesis [J] . Chunjiao Song ,Huan Chen ,Tingzhang Wang . 临床医学国际期刊（英文） . 2017,第2期
• 3. 蛋白酶体抑制剂对前列腺癌细胞生长的影响及其与雄激素受体的关系 [C] . 王利平 ,罗荣城 ,符鹏程 . 第九届中国肿瘤内科大会、第四届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2015年学术年会 . 2015
• 4. SMYD3提高雄激素受体表达促进前列腺癌发生的机制研究 [A] . 王昌 . 2013